 |
 |
Paul J. Davis, M.D.
Director, Ordway Research
Institute
Senior Scientist, Ordway Research Institute
Senior Associate Dean for Clinical Research and Professor
of Medicine,
Albany Medical College
Staff Physician, Stratton VA Medical Center, Albany,
NY
Signal Transduction Laboratory
Telephone: (518) 641-6410
Fax: (518) 641-6303
pdavis@ordwayresearch.org
Research Focus
The research focus of the Davis laboratory is
directed at understanding how thyroid hormone works on a molecular
level and what cellular effects result from these actions. Dr. Davis
and the Signal Transduction Laboratory team have found that a significant
role of this hormone is to enhance the action of cytokines and growth
factors. For example, thyroid hormone enhances the antiviral and
immunomodulatory effects of interferon-γ and of epidermal
growth factor (EGF). A collaboration with Dr. Shaker Mousa (Albany
College of Pharmacy) has disclosed that thyroid hormone is pro-angiogenic,
acting via a mechanism that is mitogen-activated protein kinase
(MAPK/ERK1/2)- and fibroblast growth factor (FGF2)-dependent.
Thyroid hormone is well known to exert its action
by means of a protein receptor located in cell nuclei. The Davis
laboratory has determined that thyroid hormone also acts by means
of a different receptor located at the plasma membrane of cells.
When this receptor is activated, a cascade of changes in protein
mediators takes place, culminating in a signal which can modify
the activity of nuclear transactivator proteins, such as STAT proteins,
p53 and members of the superfamily of nuclear hormone receptors.
The laboratory has recently identified the plasma membrane receptor
for thyroid hormone.
The laboratory also studies the mechanisms
and cellular consequences of thyroid hormone-directed post-translational
modifications (phosphorylation, acetylation) of nuclear hormone
receptors and the hormone-directed compositional changes of enhanceosomes.
Selected Publications
www.pubmed.com
Lin, H-Y, Davis, FB, Gordinier,
JK, Martino, LJ, and Davis, PJ. Thyroid hormone induces activation
of mitogen-activated protein kinase in cultured cells. Amer
J Physiol 276:C1014-C1024, 1999.
Davis, PJ, Shih, A, Lin, H-Y, Martino, LJ and
Davis, FB. Thyroxine promotes association of mitogen-activated
protein kinase and nuclear thyroid hormone receptor (TR) and causes
serine phosphorylation of TR. J Biol Chem 275:38032-38039,
2000.
Shih, A, Lin, H-Y, Davis, FB,
and Davis, PJ. Thyroid hormone promotes serine phosphorylation of
p53 by mitogen-activated protein kinase. Biochemistry 40:2870-2878,
2001.
Shih, A, Davis, FB, Lin, H-Y,
and Davis, PJ. Resveratrol induces apoptosis in thyroid cancer cell
lines via a MAPK- and p53-dependent mechanism. J Clin Endocrinol
Metab 87:1223-1232, 2002.
Lin, H-Y, Zhang, S, West, BL, Tang, H-Y,
Passaretti, T, Davis, FB and Davis, PJ. Identification
of the putative MAP kinase docking site in the thyroid hormone receptor-β1
DNA-binding domain: functional consequences of mutations at the
docking site. Biochemistry 42:7571-7579,
2003.
Back to top
|
 |
 |